A Secret Opioid Memo That Could Have Slowed an Epidemic

A confidential government document containing evidence so critical it had the potential to change the course of an American tragedy was kept in the dark for more than a decade.

Read More.

‘The Weekly’ shines a light on that 2006 Justice Department memo and its consequences for today’s wave of lawsuits against opioid makers and members of the Sackler family, which owns Purdue Pharma. We go with Barry Meier, the New York Times reporter who for two decades has chronicled how opioid abuse has ravaged America, as he travels back to where the crisis began.

* * *

Prosecutors cited evidence in their 2006 memo that Sackler family members who own Purdue were sent reports about problems with the company’s drugs. Videos for A Secret Opioid Memo That Could Have No Pre-Reading, No Rehearsing: How ‘The Weekly’ Kept Its Recreation of Historic Opioid Testimony Authentic NY Times But that evidence never came to light because the recommended felony charges against Purdue executives never went forward.

Date: 2019-08-16T09:00:13.000Z
Reference: Visit Source

Were you following this:

Morning Briefing for Thursday, August 8, 2019

A federal advisory panel says people between ages 27 and 45 may benefit from the vaccine to fight the human papillomavirus. 2:39 Chattanooga medical startup believes they have a method to solve opioid crisis YouTube But some public health advocates worry that the advice doesn’t provide doctors and patients clear guidance about who in this large age group are good candidates for the vaccine. (Michelle Andrews, 8/8)

* * *

The drug CroFab, which has been on the market since 2000, now faces competition from a drug called Anavip. But both are expensive. (Carmen Heredia Rodriguez, 8/8)

* * *

Obesity prevention does not get much attention in Colorado, often billed as the healthiest state. 6:47 The opioid industry fought hard to keep this database hidden. Here's what it shows YouTube Yet more than 1 in 4 black or Hispanic residents are obese, as state and federal public health spending fuels other needs. (Markian Hawryluk, 8/8)

Publisher: Kaiser Health News
Date: 2019-08-08T13:00:58+00:00
Twitter: @khnews
Reference: Visit Source

Deposition: Sackler embraced plan to conceal OxyContin’s strength

In May 1997, the year after Purdue Pharma launched OxyContin, its head of sales and marketing sought input on a key decision from Dr. Richard Sackler, a member of the billionaire family that founded and controls the company. The Weekly | A Secret Opioid Memo That Could Have Slowed ... www.nytimes.com /2019/08/16/the-weekly/ opioid -crisis-epidemic.html The secrecy surrounding the memo is emblematic of a legal process that favors the suppression of corporate information. If disclosed, this information could benefit the public’s health and safety. Michael Friedman told Sackler that he didn’t want to correct the false impression among doctors that OxyContin was weaker than morphine, because the myth was boosting prescriptions ‘ and sales.

Publisher: STAT
Date: 2019-02-21T18:45:42+00:00
Twitter: @statnews
Reference: Visit Source